DexCom Revenue 2010-2024 | DXCM

DexCom annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • DexCom revenue for the quarter ending September 30, 2024 was $0.994B, a 1.97% increase year-over-year.
  • DexCom revenue for the twelve months ending September 30, 2024 was $3.954B, a 16.19% increase year-over-year.
  • DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022.
  • DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021.
  • DexCom annual revenue for 2021 was $2.449B, a 27.08% increase from 2020.
DexCom Annual Revenue
(Millions of US $)
2023 $3,622
2022 $2,910
2021 $2,449
2020 $1,927
2019 $1,476
2018 $1,032
2017 $719
2016 $573
2015 $402
2014 $259
2013 $160
2012 $100
2011 $76
2010 $49
2009 $30
DexCom Quarterly Revenue
(Millions of US $)
2024-09-30 $994
2024-06-30 $1,004
2024-03-31 $921
2023-12-31 $1,035
2023-09-30 $975
2023-06-30 $871
2023-03-31 $742
2022-12-31 $815
2022-09-30 $770
2022-06-30 $696
2022-03-31 $629
2021-12-31 $698
2021-09-30 $650
2021-06-30 $595
2021-03-31 $505
2020-12-31 $569
2020-09-30 $501
2020-06-30 $452
2020-03-31 $405
2019-12-31 $463
2019-09-30 $396
2019-06-30 $336
2019-03-31 $281
2018-12-31 $338
2018-09-30 $267
2018-06-30 $243
2018-03-31 $184
2017-12-31 $221
2017-09-30 $185
2017-06-30 $171
2017-03-31 $142
2016-12-31 $171
2016-09-30 $149
2016-06-30 $137
2016-03-31 $116
2015-12-31 $131
2015-09-30 $105
2015-06-30 $93
2015-03-31 $73
2014-12-31 $84
2014-09-30 $69
2014-06-30 $59
2014-03-31 $47
2013-12-31 $52
2013-09-30 $43
2013-06-30 $36
2013-03-31 $30
2012-12-31 $33
2012-09-30 $23
2012-06-30 $23
2012-03-31 $20
2011-12-31 $22
2011-09-30 $18
2011-06-30 $21
2011-03-31 $14
2010-12-31 $16
2010-09-30 $12
2010-06-30 $12
2010-03-31 $10
2009-12-31 $10
2009-09-30 $7
2009-06-30 $7
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $27.225B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.467B 25.92
Intuitive Surgical (ISRG) United States $180.733B 94.49
Alcon (ALC) Switzerland $45.462B 32.00
Edwards Lifesciences (EW) United States $40.042B 24.90
IQVIA Holdings (IQV) United States $38.149B 21.02
IDEXX Laboratories (IDXX) United States $33.943B 39.97
Waters (WAT) United States $22.999B 34.01
STERIS (STE) Ireland $22.270B 25.99
SONOVA HOLDING (SONVY) Switzerland $21.961B 0.00
Hologic (HOLX) United States $19.446B 20.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.766B 13.19
Sysmex ADR (SSMXY) Japan $11.599B 36.37
Globus Medical (GMED) United States $10.118B 28.30
Teleflex (TFX) United States $9.629B 15.36
Penumbra (PEN) United States $8.808B 86.28
Masimo (MASI) United States $7.841B 41.99
Glaukos (GKOS) United States $7.219B 0.00
PROCEPT BioRobotics (PRCT) United States $5.065B 0.00
Integer Holdings (ITGR) United States $4.244B 24.06
Inari Medical (NARI) United States $2.865B 0.00
TransMedics (TMDX) United States $2.852B 90.39
Veracyte (VCYT) United States $2.687B 166.57
LivaNova (LIVN) United Kingdom $2.661B 15.36
Nihon Kohden (NHNKY) Japan $2.561B 15.94
Elekta AB (EKTAY) Sweden $2.323B 18.92
Tandem Diabetes Care (TNDM) United States $2.151B 0.00
RxSight (RXST) United States $1.896B 0.00
Integra LifeSciences Holdings (IART) United States $1.871B 9.73
Alphatec Holdings (ATEC) United States $1.185B 0.00
Artivion (AORT) United States $1.150B 105.61
OPKO Health (OPK) United States $1.032B 0.00
Pulse Biosciences (PLSE) United States $0.934B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.883B 15.01
OrthoPediatrics (KIDS) United States $0.696B 0.00
Pacific Biosciences Of California (PACB) United States $0.684B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.662B 0.00
Mesa Laboratories (MLAB) United States $0.641B 16.18
IRadimed (IRMD) United States $0.626B 33.81
AxoGen (AXGN) United States $0.622B 0.00
SiBone (SIBN) United States $0.568B 0.00
Paragon 28 (FNA) United States $0.506B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.359B 19.62
ClearPoint Neuro (CLPT) United States $0.352B 0.00
Treace Medical Concepts (TMCI) United States $0.338B 0.00
Delcath Systems (DCTH) United States $0.299B 0.00
AngioDynamics (ANGO) United States $0.274B 0.00
Sight Sciences (SGHT) United States $0.234B 0.00
Inogen (INGN) United States $0.214B 0.00
Semler Scientific (SMLR) United States $0.210B 14.62
Nevro (NVRO) United States $0.199B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Accuray (ARAY) United States $0.180B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.122B 0.00
908 Devices (MASS) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.104B 15.51
EDAP TMS S.A (EDAP) France $0.100B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Baird Medical Investment Holdings (BDMD) $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00